286 related articles for article (PubMed ID: 29909790)
21. Olanzapine for schizophrenia.
Duggan L; Fenton M; Rathbone J; Dardennes R; El-Dosoky A; Indran S
Cochrane Database Syst Rev; 2005 Apr; (2):CD001359. PubMed ID: 15846619
[TBL] [Abstract][Full Text] [Related]
22. Preventing the second episode: a systematic review and meta-analysis of psychosocial and pharmacological trials in first-episode psychosis.
Alvarez-Jiménez M; Parker AG; Hetrick SE; McGorry PD; Gleeson JF
Schizophr Bull; 2011 May; 37(3):619-30. PubMed ID: 19900962
[TBL] [Abstract][Full Text] [Related]
23. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T
Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555
[TBL] [Abstract][Full Text] [Related]
24. Risperidone versus typical antipsychotic medication for schizophrenia.
Hunter RH; Joy CB; Kennedy E; Gilbody SM; Song F
Cochrane Database Syst Rev; 2003; (2):CD000440. PubMed ID: 12804396
[TBL] [Abstract][Full Text] [Related]
25. Quetiapine for schizophrenia.
Srisurapanont M; Maneeton B; Maneeton N
Cochrane Database Syst Rev; 2004; 2004(2):CD000967. PubMed ID: 15106155
[TBL] [Abstract][Full Text] [Related]
26. Benzodiazepines for schizophrenia.
Volz A; Khorsand V; Gillies D; Leucht S
Cochrane Database Syst Rev; 2007 Jan; (1):CD006391. PubMed ID: 17253592
[TBL] [Abstract][Full Text] [Related]
27. Long-acting antipsychotic medication as first-line treatment of first-episode psychosis with comorbid substance use disorder.
Abdel-Baki A; Thibault D; Medrano S; Stip E; Ladouceur M; Tahir R; Potvin S
Early Interv Psychiatry; 2020 Feb; 14(1):69-79. PubMed ID: 31125513
[TBL] [Abstract][Full Text] [Related]
28. Predicting 1-year risk for relapse in patients who have discontinued or continued quetiapine after remission from first-episode psychosis.
Hui CL; Wong GH; Tang JY; Chang WC; Chan SK; Lee EH; Lam MM; Chiu CP; Law CW; Chung DW; Tso S; Pang EP; Chan KT; Wong YC; Mo FY; Chan KP; Hung SF; Honer WG; Chen EY
Schizophr Res; 2013 Oct; 150(1):297-302. PubMed ID: 23993865
[TBL] [Abstract][Full Text] [Related]
29. Recurrence rates in stable bipolar disorder patients after drug discontinuation
Kishi T; Matsuda Y; Sakuma K; Okuya M; Mishima K; Iwata N
Psychol Med; 2021 Nov; 51(15):2721-2729. PubMed ID: 33046156
[TBL] [Abstract][Full Text] [Related]
30. New generation antipsychotics for first episode schizophrenia.
Rummel C; Hamann J; Kissling W; Leucht S
Cochrane Database Syst Rev; 2003; (4):CD004410. PubMed ID: 14584012
[TBL] [Abstract][Full Text] [Related]
31. Maintenance treatment with quetiapine versus discontinuation after one year of treatment in patients with remitted first episode psychosis: randomised controlled trial.
Chen EY; Hui CL; Lam MM; Chiu CP; Law CW; Chung DW; Tso S; Pang EP; Chan KT; Wong YC; Mo FY; Chan KP; Yao TJ; Hung SF; Honer WG
BMJ; 2010 Aug; 341():c4024. PubMed ID: 20724402
[TBL] [Abstract][Full Text] [Related]
32. Randomised controlled trial of gradual antipsychotic reduction and discontinuation in people with schizophrenia and related disorders: the RADAR trial (Research into Antipsychotic Discontinuation and Reduction).
Moncrieff J; Lewis G; Freemantle N; Johnson S; Barnes TRE; Morant N; Pinfold V; Hunter R; Kent LJ; Smith R; Darton K; Horne R; Crellin NE; Cooper RE; Marston L; Priebe S
BMJ Open; 2019 Nov; 9(11):e030912. PubMed ID: 31780589
[TBL] [Abstract][Full Text] [Related]
33. Long-term effects of discontinuation from antipsychotic maintenance following first-episode schizophrenia and related disorders: a 10 year follow-up of a randomised, double-blind trial.
Hui CLM; Honer WG; Lee EHM; Chang WC; Chan SKW; Chen ESM; Pang EPF; Lui SSY; Chung DWS; Yeung WS; Ng RMK; Lo WTL; Jones PB; Sham P; Chen EYH
Lancet Psychiatry; 2018 May; 5(5):432-442. PubMed ID: 29551618
[TBL] [Abstract][Full Text] [Related]
34. Pimozide for schizophrenia or related psychoses.
Mothi M; Sampson S
Cochrane Database Syst Rev; 2013 Nov; (11):CD001949. PubMed ID: 24194433
[TBL] [Abstract][Full Text] [Related]
35. Risk of symptom recurrence with medication discontinuation in first-episode psychosis: a systematic review.
Zipursky RB; Menezes NM; Streiner DL
Schizophr Res; 2014 Feb; 152(2-3):408-14. PubMed ID: 23972821
[TBL] [Abstract][Full Text] [Related]
36. Bromperidol decanoate (depot) for schizophrenia.
Purgato M; Adams CE
Cochrane Database Syst Rev; 2011 Sep; (9):CD001719. PubMed ID: 21901678
[TBL] [Abstract][Full Text] [Related]
37. Risperidone versus olanzapine for schizophrenia.
Jayaram MB; Hosalli P; Stroup S
Cochrane Database Syst Rev; 2006 Apr; (2):CD005237. PubMed ID: 16625629
[TBL] [Abstract][Full Text] [Related]
38. Aripiprazole for schizophrenia.
El-Sayeh HG; Morganti C
Cochrane Database Syst Rev; 2006 Apr; (2):CD004578. PubMed ID: 16625607
[TBL] [Abstract][Full Text] [Related]
39. You say "schizophrenia" and I say "psychosis": Just tell me when I can come off this medication.
Zipursky RB; Odejayi G; Agid O; Remington G
Schizophr Res; 2020 Nov; 225():39-46. PubMed ID: 32115315
[TBL] [Abstract][Full Text] [Related]
40. Negative symptoms predict high relapse rates and both predict less favorable functional outcome in first episode psychosis, independent of treatment strategy.
Wunderink L; van Bebber J; Sytema S; Boonstra N; Meijer RR; Wigman JTW
Schizophr Res; 2020 Feb; 216():192-199. PubMed ID: 31866076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
